Acadia Healthcare Company, Inc. (ACHC) is a publicly traded Healthcare sector company. As of May 20, 2026, ACHC trades at $24.07 with a market cap of $2.33B and a P/E ratio of -2.01. ACHC moved -3.39% today. Year to date, ACHC is +68.56%; over the trailing twelve months it is -4.48%. Its 52-week range spans $11.43 to $64.89. Analyst consensus is buy with an average price target of $28.23. Rallies surfaces ACHC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies organizes ACHC SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
| Metric | Value |
|---|---|
| Price | $24.07 |
| Market Cap | $2.33B |
| P/E Ratio | -2.01 |
| EPS | $-12.16 |
| Dividend Yield | 0.00% |
| 52-Week High | $64.89 |
| 52-Week Low | $11.43 |
| Volume | 1.25M |
| Avg Volume | 0 |
| Revenue (TTM) | $3.31B |
| Net Income | $-1.09B |
| Gross Margin | 0.00% |
11 analysts cover ACHC: 0 strong buy, 6 buy, 4 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $28.23.